Budesonide 'beneficial' for risky patients with mild COVID-19

Although GPs can prescribe new oral treatments, they’re in short supply

Inhaled budesonide remains a useful option for treating symptoms of mild COVID-19 despite the advent of new oral antivirals, the RACGP’s quality care spokesman says.

Professor Mark Morgan
Associate Professor Mark Morgan.

The corticosteroid is the only drug suggested by the National COVID-19 Clinical Evidence Taskforce as a disease-modifying treatment for mild and moderate COVID-19 that’s not an oral antiviral or monoclonal antibody.